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Background: The aim of this study was to determine whether the serotonin transporter gene (5-HTT), a key
component in the control of the serotonergic system, is associated with endometriosis in an Italian population.
Findings: A case–control study, comprising 137 Italian patients with surgically confirmed endometriosis and
120 healthy controls, was carried out. 5-HTT genotypes (LL, SL and SS) were obtained by polymerase chain
reaction and gel electrophoresis analysis. We found no overall difference in genotypic and allelic distributions
of the 5-HTT gene between cases and controls.
Conclusions: Our results suggest that the 5-HTT L/S promoter polymorphism is not associated with susceptibility
to endometriosis in the studied Italian patients.
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Introduction
Endometriosis is a gynecological condition characterized
by the presence of ectopic endometrial tissue (endometrial
glands and stroma) outside the uterus associated with
pelvic pain and infertility [1]. The disease affects 6-10% of
women in reproductive age with or without pelvic pain
and more than 30% of infertile women [2-4]. Endometri-
osis has a multifactorial inheritance: environmental pollut-
ants, particularly dioxins and polychlorinated biphenyls
(PCBs) and genetic predisposition have been suggested to
concur to the onset and progression of this disease [5-8].
Endometriosis varies from a mild disease with only peri-
toneal lesions to a severe form involving both ovaries
associated with infiltrating foci and extensive adhesions.
Women with endometriosis may have a range of pelvic
and abdominal pain symptoms, including dysmenorrhoea,
dyspareunia, non-menstrual (chronic) pelvic pain, pain at
ovulation, dyschezia and dysuria [9,10]. Endometriosis and
its symptoms tend to recur after treatment [11]. Pain* Correspondence: francesca.megiorni@uniroma1.it
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unless otherwise stated.symptoms significantly vary among patients and do not
always correlate with the severity of endometriosis [9,12,13]
suggesting that other factors, such as psychological factors,
altered stress response and emotional factors may influence
the perception of pain [14]. Alterations in the immune sys-
tem, such as an increase in activated peritoneal immune
cells and pro-inflammatory factors, seem to be involved
in the pathogenesis of endometriosis [15]. Serotonin
(5-hydroxytryptamine; 5-HT) is a neurotransmitter that
participates in many physiological processes such as sleep,
appetite, pain perception, hormone secretion, and sexual
behavior [16]. 5-HT is also able to regulate important
functions outside of the CNS (central nervous system),
such as vasoconstriction, proliferation and insulin secretion,
and can trigger inflammatory mechanisms [17,18]. Sero-
tonin transporter (5-HTT) uptakes 5-HT from the synaptic
cleft and plays a critical role in the termination of the sero-
tonergic system, such as stress response. Recent findings
have suggested that a 5-HTT-dependent mechanism is also
involved in the pathogenesis of autoimmune and chronic
inflammatory diseases [19]. Human 5-HTT gene maps on
chromosome 17q11.1-12 and its expression is regulated at
the transcriptional level by the presence/absence of aal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Figure 1 Genotyping of 5-HTT L/S polymorphism using PCR/
agarose gel electrophoresis. Example of SL, LL and SS genotypes.
Table 1 Allele and genotype frequencies of the 5-HTT gene
polymorphism in patients with endometriosis and controls
5-HTT Patients (137) Controls (120)
n % n %
Allele
S 117 (42.7%) 104 (43.3%)
L 157 (57.3%) 136 (56.7%)
Genotype
SS 28 (20.5%) 25 (20.8%)
SL 61 (44.5%) 54 (45.0%)
LL 48 (35.0%) 41 (34.2%)
Dominant model
SS + SL 89 (65.0%) 79 (65.8%)
LL 48 (35.0%) 41 (34.2%)
The genetic model was considered dominant in the hypothesis that the S variant
is a risk factor for the disease.
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leading to two different variants referred to as L (Long) and
S (Short). S allele is associated with low levels of 5-HTT
mRNA and therefore with a reduced serotonin re-uptake.
SL or SS subjects have a greater tendency to stress com-
pared to LL homozygous individuals [20]. Therefore, by
regulating the magnitude and duration of serotonergic and
neuroendocrine responses, 5-HTT expression is central to
the fine-tuning of both brain serotonergic neurotransmis-
sion and immunomodulatory effects.
The aim of the present study was to assess the role of
genetic factors in the etiopathogenesis of endometriosis
linked to the genotype of the serotonin transporter gene
regulatory region compared with healthy women.
Materials and methods
Patients and controls
In total 137 unrelated Caucasian patients from peninsular
Italy, ranging from unskilled workers to university gradu-
ates, were included in the study. All had endometriosis
and mean age was 37.1 ± 7.7 years. Diagnosis of endomet-
riosis was achieved by laparoscopy and histologic analysis.
As healthy controls, 120 women from the same ethnic
area were enrolled with mean age 35.2 ± 11.2 years and
pelvic examination and transvaginal ultrasound were per-
formed and all results were normal. Laparoscopy was not
performed systematically, but when available, it showed
normal results. All patients were recruited from the
Department of Gynecology and Obstetrics – Policlinico
Umberto I, “Sapienza” University of Rome, Italy. The
Institutional Review Board of the University Hospital
Azienda Policlinico Umberto I approved the study proto-
col and all subjects provided their informed consent.
DNA extraction and 5-HTTLPR genotyping
Genomic DNA was extracted from 5 ml peripheral ven-
ous blood using a salting-out procedure [21]. The L/S
(long allele-L/short allele-S) polymorphism in the pro-
moter region of the 5-HTT gene consisting of an inser-
tion/deletion (long allele-L/short allele-S) of 44 base pair
(bp) was amplified by polymerase chain reaction (PCR)
using 5-HTT-forward: 5’-GGCGTTGCCGCTCTGAAT
GC-3’ and 5-HTT-reverse: 5’-GAGGGACTGAGCTGG
ACAACCAC-3’ primers. PCR conditions were as follows:
denaturation for 4 min at 95°C, 35 cycles of 45 sec at 95°C,
45 sec at 67°C and 90 sec at 72°C, followed by 5 min
at 72°C. PCR products were separated in 2% agarose gels
with ethidium bromide and visualized under Ultraviolet
(UV) light. Band patterns of the different combinations of
S (485 bp) and L alleles (529 bp) are shown in Figure 1.
Statistical analysis
All basic statistical analyses were performed with the
Statistical Product and Service Solutions software (SPSS)version 17.0 WIN program (SPSS, Chicago, Illinois). The
χ2 or Fisher’s exact tests were used to compare differ-
ences between categorical variables. A p-value <0.05 was
considered statistically significant. 5-HTT genotype dis-
tribution was evaluated for Hardy-Weinberg equilibrium
by GenAlEx 6 (Genetic analysis in Excel) software [22].
Results
To investigate whether the 5-HTT L/S polymorphism
was associated with endometriosis in Italian female
population, we compared 137 unrelated patients with
120 healthy women. Genotype distribution resulted in
Hardy-Weinberg equilibrium in both cases and controls
(data not shown). Table 1 summarizes the allele and
genotype frequencies of 5-HTT in affected and healthy
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in both groups (57.3% in cases and 56.7% in controls),
whereas S allele was present less frequently (42.7% in
cases and 43.3% in controls). The distribution of the
three different genotypes did not show any significant
differences between patients and control subjects (Table 1).
In an inheritance model in which S is the dominant allele
and the risk factor for endometriosis, the prevalence
of SL heterozygotes and SS homozygotes, collectively
considered, resulted comparable in affected women and
controls (65.0% vs. 65.8%). In all, our results indicate that
the presence of the 5-HTT S variant is not associated with
the risk of endometriosis.
Comment
The aim of this study was to elucidate a possible role of
the functional L/S polymorphism in the serotonin trans-
porter gene (5-HTT) in patients with endometriosis
since the axis 5-HT/5-HTT has been correlated with
alterations of both immune and stress response [19,20].
The results of our case–control study failed to show an
association between the 5-HTT L/S variants and endo-
metriosis susceptibility. Furthermore, this gene poly-
morphism of the serotoninergic system seems to be not
associated with clinical features of endometriosis, but this
was possible due to the small number of patients available
in the present study. Our analysis cannot rule out the pos-
sible involvement of other genes that have been related to
reactions to stress and/or inflammation, such as 5-HT2A
receptor 102 T/C polymorphisms, suggesting the seroto-
nergic system may play a role in the pathogenesis of endo-
metriosis. Additional studies including larger number
of patients and controls are required to elucidate can-
didate genes that are likely to be involved in both the
sensory and affective components of pain linked to
endometriosis.
In conclusion, this study shows that the 5-HTT L/S
promoter polymorphism seems not to confer susceptibility
to endometriosis in the Italian population.
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